NASDAQ: INCR
Intercure Ltd Stock Ownership - Who owns Intercure?

Insider buying vs selling

Have Intercure Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INCR insiders and whales buy or sell their stock.

INCR Shareholders

What type of owners hold Intercure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ibex Investors LLC4.00%1,886,274$2.77MInstitution
Healthcare Of Ontario Pension Plan Trust Fund0.45%212,500$312.38kInstitution
Advisorshares Investments LLC0.23%108,884$160.06kInstitution
Moore Capital Management LP0.21%97,273$142.99kInstitution
Renaissance Technologies LLC0.10%48,900$71.88kInstitution
Citadel Advisors LLC0.09%41,068$60.37kInstitution
Blackrock Inc0.05%24,162$35.52kInstitution
Geode Capital Management LLC0.05%22,539$33.13kInstitution
Revisor Wealth Management LLC0.03%12,648$18.59kInstitution
Quent Capital LLC0.02%10,321$15.17kInstitution

1 of 3

INCR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCR5.29%0.00%
BGM1.83%0.00%
ASRT26.03%21.24%Net Selling
CPIX24.61%55.86%Net BuyingNet Buying
QNTM3.36%0.00%

Intercure Stock Ownership FAQ

Who owns Intercure?

Intercure (NASDAQ: INCR) is owned by 5.29% institutional shareholders, 0.00% Intercure insiders, and 94.71% retail investors. Ibex Investors LLC is the largest individual Intercure shareholder, owning 1.89M shares representing 4.00% of the company. Ibex Investors LLC's Intercure shares are currently valued at $2.85M.

If you're new to stock investing, here's how to buy Intercure stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.